Analysis of the full-length integrase-DNA complex by a modified approach for DNA docking

Biochemical and Biophysical Research Communications

Volumn 310, Issue 4, 2003, Pages 1083-1088

  De Luca, Laura ^a   Pedretti, Alessandro ^b   Vistoli, Giulio ^b   Barreca, Maria Letizia ^a   Villa, Luigi ^b   Monforte, Pietro ^a   Chimirri, Alba ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

DNA protein docking; Full length IN DNA complex; HIV 1 integrase

Indexed keywords

DIMER; DOCKING PROTEIN; INTEGRASE; VIRUS DNA; VIRUS PROTEIN;

ANALYTIC METHOD; ARTICLE; COMPUTER PROGRAM; CROSS LINKING; DNA MODIFICATION; DNA PROTEIN COMPLEX; DNA STRUCTURE; MOLECULAR MODEL; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN MODIFICATION; PROTEIN STRUCTURE;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0141927229     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2003.09.120     Document Type: Article

References (44)

1. d'Angelo J., Mouscadet J.F., Desmaele D., Zouhiri F., Leh H. HIV-1 integrase: the next target for AIDS therapy? Pathol. Biol. (Paris). 49:2001;237-246.
2. Chow S.A., Vincent K.A., Ellison V., Brown P.O. Reversal of integration and DNA splicing mediated by integrase of human immunodeficiency virus. Science. 255:1992;723-726.
3. Zheng R., Jenkins T.M., Craigie R. Zinc folds the N-terminal domain of HIV-1 integrase, promotes multimerization, and enhances catalytic activity. Proc. Natl. Acad. Sci. USA. 93:1996;13659-13664.
4. 2+ promotes the self-association of human immunodeficiency virus type-1 integrase in vitro. Biochemistry. 36:1997;173-180.
5. Engelman A., Craigie R. Identification of conserved amino acid residues critical for human immunodeficiency virus type 1 integrase function in vitro. J. Virol. 66:1992;6361-6369.
6. Kulkosky J., Jones K.S., Katz R.A., Mack J.P., Skalka A.M. Residues critical for retroviral integrative recombination in a region that is highly conserved among retroviral/retrotransposon integrases and bacterial insertion sequence transposases. Mol. Cell. Biol. 12:1992;2331-2338.
7. Polard P., Chandler M. Bacterial transposases and retroviral integrases. Mol. Microbiol. 15:1995;13-23.
8. Vink C., Oude Groeneger A.M., Plasterk R.H. Identification of the catalytic and DNA-binding region of the human immunodeficiency virus type I integrase protein. Nucleic Acids Res. 21:1993;1419-1425.
9. Bushman F.D., Engelman A., Palmer I., Wingfield P., Craigie R. Domains of the integrase protein of human immunodeficiency virus type 1 responsible for polynucleotidyl transfer and zinc binding. Proc. Natl. Acad. Sci. USA. 90:1993;3428-3432.
10. Dyda F., Hickman A.B., Jenkins T.M., Engelman A., Craigie R., Davies D.R. Crystal structure of the catalytic domain of HIV-1 integrase: similarity to other polynucleotidyl transferases. Science. 266:1994;1981-1986.
11. Bujacz G., Alexandratos J., Qing Z.L., Clement-Mella C., Wlodawer A. The catalytic domain of human immunodeficiency virus integrase: ordered active site in the F185H mutant. FEBS Lett. 398:1996;175-178.
12. Maignan S., Guilloteau J.P., Zhou-Liu Q., Clement-Mella C., Mikol V. Crystal structures of the catalytic domain of HIV-1 integrase free and complexed with its metal cofactor: high level of similarity of the active site with other viral integrases. J. Mol. Biol. 282:1998;359-368.
13. Goldgur Y., Craigie R., Cohen G.H., Fujiwara T., Yoshinaga T., Fujishita T., Sugimoto H., Endo T., Murai H., Davies D.R. Structure of the HIV-1 integrase catalytic domain complexed with an inhibitor: a platform for antiviral drug design. Proc. Natl. Acad. Sci. USA. 96:1999;13040-13043.
14. Greenwald J., Le V., Butler S.L., Bushman F.D., Choe S. The mobility of an HIV-1 integrase active site loop is correlated with catalytic activity. Biochemistry. 38:1999;8892-8893.
15. Eijkelenboom A.P., Lutzke R.A., Boelens R., Plasterk R.H., Kaptein R., Hard K. The DNA-binding domain of HIV-1 integrase has an SH3-like fold. Nat. Struct. Biol. 2:1995;807-810.
16. Eijkelenboom A.P., Sprangers R., Hard K., Puras Lutzke R.A., Plasterk R.H., Boelens R., Kaptein R. Refined solution structure of the C-terminal DNA-binding domain of human immunovirus-1 integrase. Proteins. 36:1999;556-564.
17. Lodi P.J., Ernst J.A., Kuszewski J., Hickman A.B., Engelman A., Craigie R., Clore G.M., Gronenborn A.M. Solution structure of the DNA binding domain of HIV-1 integrase. Biochemistry. 34:1995;9826-9833.
18. Cai M., Huang Y., Caffrey M., Zheng R., Craigie R., Clore G.M., Gronenborn A.M. Solution structure of the His12. → Cys mutant of the N-terminal zinc binding domain of HIV-1 integrase complexed to cadmium Protein Sci. 7:1998;2669-2674.
19. Cai M., Zheng R., Caffrey M., Craigie R., Clore G.M., Gronenborn A.M. Solution structure of the N-terminal zinc binding domain of HIV-1 integrase. Nat. Struct. Biol. 4:1997;567-577.
20. Chen J.C., Krucinski J., Miercke L.J., Finer-Moore J.S., Tang A.H., Leavitt A.D., Stroud R.M. Crystal structure of the HIV-1 integrase catalytic core and c-terminal domains: a model for viral DNA binding. Proc. Natl. Acad. Sci. USA. 97:2000;8233-8238.
21. Wang J.Y., Ling H., Yang W., Craigie R. Structure of a two-domain fragment of HIV-1 integrase: implications for domain organization in the intact protein. EMBO J. 20:2001;7333-7343.
22. Molteni V., Greenwald J., Rhodes D., Hwang Y., Kwiatkowski W., Bushman F.D., Siegel J.S., Choe S. Identification of a small-molecule binding site at the dimer interface of the HIV integrase catalytic domain. Acta Crystallogr. D. Biol. Crystallogr. 57:2001;536-544.
23. Gao K., Butler S.L., Bushman F. Human immunodeficiency virus type 1 integrase: arrangement of protein domains in active cDNA complexes. EMBO J. 20:2001;3565-3576.
24. Heuer T.S., Brown P.O. Photo-cross-linking studies suggest a model for the architecture of an active human immunodeficiency virus type 1 integrase-DNA complex. Biochemistry. 37:1998;6667-6678.
25. Podtelezhnikov A.A., Gao K., Bushman F.D., McCammon J.A. Modeling HIV-1 integrase complexes based on their hydrodynamic properties. Biopolymers. 68:2003;110-120.
26. Halperin I., Ma B., Wolfson H., Nussinov R. Principles of docking: an overview of search algorithms and a guide to scoring functions. Proteins. 47:2002;409-443.
27. Pabo C.O., Nekludova L. Geometric analysis and comparison of protein-DNA interfaces: why is there no simple code for recognition? J. Mol. Biol. 301:2000;597-624.
28. Ausiello G., Cesareni G., Helmer-Citterich M. ESCHER: a new docking procedure applied to the reconstruction of protein tertiary structure. Proteins. 28:1997;556-567.
29. Goldgur Y., Dyda F., Hickman A.B., Jenkins T.M., Craigie R., Davies D.R. Three new structures of the core domain of HIV-1 integrase: an active site that binds magnesium. Proc. Natl. Acad. Sci. USA. 95:1998;9150-9154.
30. Bujacz G., Jaskolski M., Alexandratos J., Wlodawer A., Merkel G., Katz R.A., Skalka A.M. The catalytic domain of avian sarcoma virus integrase: conformation of the active-site residues in the presence of divalent cations. Structure. 4:1996;89-96.
31. Brook B.R., Bruccoleri R.E., Olafson B.D., States D.J., Swaminathan S., Karplus M. CHARMM: a program for macromolecular energy, minimization and dynamics calculations. J. Comput. Chem. 4:1983;187-217.
32. Ramachandran G.N., Saisekharan V. Conformation of polypeptides and proteins. Adv. Protein Chem. 23:1968;283-437.
33. Luthy R., Bowie J.U., Eisenberg D. Assessment of protein models with three-dimensional profile. Nature. 356:1992;83-85. http://www.doe-mbi.ucla.edu/Services/Verify_3D.
34. InsightII, Accelrys Inc, San Diego, CA, USA, 2001.
35. Espeseth A.S., Felock P., Wolfe A., Witmer M., Grobler J., Anthony N., Egbertson M., Melamed J.Y., Young S., Hamill T., Cole J.L., Hazuda D.J. HIV-1 integrase inhibitors that compete with the target DNA substrate define a unique strand transfer conformation for integrase. Proc. Natl. Acad. Sci. USA. 97:2000;11244-11249.
36. Eisenhaber F., Lijnzaad P., Argos P., Sander C., Scharf M. The double cubic lattice method: efficient approaches to numerical integration of surface area and volume and to dot surface contouring of molecular assemblies. J. Comp. Chem. 16:1995;273-284.
37. Hazuda D.J., Felock P., Witmer M., Wolfe A., Stillmock K., Grobler J.A., Espeseth A., Gabryelski L., Schleif W., Blau C., Miller M.D. Inhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cells. Science. 287:2000;646-650.
38. Jenkins T.M., Esposito D., Engelman A., Craigie R. Critical contacts between HIV-1 integrase and viral DNA identified by structure-based analysis and photo-crosslinking. EMBO J. 16:1997;6849-6859.
39. Gerton J.L., Ohgi S., Olsen M., DeRisi J., Brown P.O. Effects of mutations in residues near the active site of human immunodeficiency virus type 1 integrase on specific enzyme-substrate interactions. J. Virol. 72:1998;5046-5055.
40. Lutzke R.A., Plasterk R.H. Structure-based mutational analysis of the C-terminal DNA-binding domain of human immunodeficiency virus type 1 integrase: critical residues for protein oligomerization and DNA binding. J. Virol. 72:1998;4841-4848.
41. Lodi P.J., Ernst J.A., Kuszewski J., Hickman A.B., Engelman A., Craigie R., Clore G.M., Gronenborn A.M. Solution structure of the DNA binding domain of HIV-1 integrase. Biochemistry. 34:1995;9826-9833.
42. Lins R.D., Adesokan A., Soares T.A., Briggs J.M. Investigations on human immunodeficiency virus type 1 integrase/DNA binding interactions via molecular dynamics and electrostatics calculations. Pharmacol. Therap. 85:2000;123-131.
43. McDonald I.K., Thornton J.M. Satisfying hydrogen bonding potential in proteins. J. Mol. Biol. 238:1994;777-793.
44. W.L. DeLano, The PyMOL Molecular Graphics System (2002) on World Wide Web. Available from: « http://www.pymol.org ».